Capricor Therapeutics Completes $172.5 Million Public Offering of Common Stock

Leila Ahmed North America Legal Chronicle
Tagged:

Sidley Austin has advised Capricor Therapeutics. Mintz has advised the underwriters. Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company, has completed an underwritten public offering of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here